← All trials
NCT07120828
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2025
- Primary completion
- Mar 1, 2026
- Completion date
- May 1, 2026
- First posted
- Aug 13, 2025
- Last posted
- Aug 13, 2025
- Enrollment
- 260
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Erbil Polytechnic UniversityLead sponsor
- Kurdistan Board for Medical SpecialistCollaborator
- Kurdistan Board for Medical SpecialistSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.